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Background: Benign metastasizing leiomyoma (BML) occurs in a low proportion of uterine leiomyomas and
treatment methods for BML are diverse and controversial. The study introduces preliminary experiences in the
diagnosis and treatment of BML with the purpose of finding a suitable management strategy for these patients.
Methods: Three patients with BML were treated in our department from April 2008 to July 2012. Each of these
patients presented with multiple nodules in both lungs, where we performed video-assisted thoracoscopic wedge
resection to harvest enough tissue for histopathologic and immunohistochemical examination. The patients were
treated with medical castration or surgical castration after the diagnosis of BML.
Results: The ultimate pathologic results ruled out the possibility of leiomyosarcoma and other metastatic diseases,
and confirmed that the pulmonary lesions were BML. The lung lesions remained stable in two patients who were
treated by surgical castration, and the lung nodules regressed in one patient treated with gonadotropin-releasing
hormone analogues.
Conclusions: The diagnosis of BML is based on the medical history of uterine myomas and histopathologic and
immunohistochemical examination of lung nodules. Video-assisted thoracoscopic wedge resection is the best way
to harvest tissue for diagnosis. The better outcomes in BML seem to call for medical intervention, either chemical or
surgical, after diagnosis is made.
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Metastasis is the capacity of cancer cells to spread from
a primary site to form tumors at distant sites in the
body; it is the hallmark of malignant disease. However,
some non-cancerous tumors, despite their benign ap-
pearance, show a low-grade clinical malignant behavior
and present a rare manifestation. Uterine leiomyoma,
the most common form of uterine tumors, is considered
a benign tumor. However, it may present with an unusual
growth pattern termed benign metastasizing leiomyoma
(BML), which occurs in a low proportion of uterine
leiomyomas. Due to the low morbidity and scarcity of* Correspondence: hqchen1@yahoo.com
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reproduction in any medium, provided the orreports on this condition, there is no consensus on which
methods should be used to treat this disease. Herein, we
present three cases of Chinese women with extensive
lung metastases after uterine leiomyoma resection, and
introduce our preliminary experiences in the diagnosis
and treatment of BML. These patients might benefit from
castration, either chemical or surgical, after diagnosis of
BML. Written informed consent was obtained from the
patient for the publication of this report and any accom-
panying images.Methods
Three patients with benign metastasizing leiomyoma
have been treated in our department from April 2008
to July 2012. They all underwent a pulmonary wedge
resection by video-assisted thoracoscopic surgery (VATS),
histopathological and immunohistochemical examina-
tions were carried out in all patients. The patients weretd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Computed tomography scan shows that lesions are generally smooth and diffusely distributed in both lungs.
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after the diagnosis of BML. The detailed information are
given below.
Case 1
A 47-year-old woman was referred to our department for
multiple nodules in both lungs found by routine examin-
ation (Figure 1). She had received subtotal hysterectomy
seven years previously for multiple leiomyomas of the
uterus and bilateral subtotal thyroidectomy three years pre-
viously for benign bilateral thyroid nodules. There was no
history of malignancy, 18F-fluorodeoxyglucose positron
emission tomography/computed tomography (18F-FDG
PET-CT) did not show 18F-FDG uptake in both lung
nodules and other parts of the body. To establish a
diagnosis, we performed a pulmonary wedge resection
by video-assisted thoracoscopic surgery and resected
the largest tumor, which was located at the periphery
of the left lung. Histopathologic examination and immu-
nohistochemical staining of resected specimens wereFigure 2 Histopathologic examination showed tumor consisted of we
cellular variance in size and shape; there were no mitotic figures
(Magnifications: A, B, and C 20×; D, E, and F 40×).performed. The pathologic report revealed that tumors
were well-circumscribed in resected specimens of the
lung, and consisted of well-differentiated spindle-shaped
cells with low nuclear and cellular variance in size and
shape; there were no mitotic figures and nuclear atypia
(Figure 2A, D). Immunohistochemical staining for
α-smooth muscle actin (α-SMA), muscle specific actin
(MSA), and desmin was positive (Figure 3A–C). The
presence of the smooth muscle protein caldesmon and
muscle marker calponin were also confirmed by immu-
nohistochemistry in this case. Immunohistochemical
analysis also showed strong expression of estrogen and
progesterone receptors on the tumor cells (Figure 3D,E).
Immunohistochemical analyses are shown in Table 1.
The ultimate pathologic results ruled out the possibility
of leiomyosarcoma and other metastatic diseases, and
confirmed that the pulmonary lesions were BML. The
patient was treated with gonadotropin-releasing hor-
mone (GnRH) agonist after thoracic surgery, Zoladex
(goserelin acetate) was administered subcutaneouslyll-differentiated spindle-shaped cells with low nuclear and
and nuclear atypia. Case 1 (A,D); Case 2 (B,E); Case 3 (C,F)
Figure 3 Immunohistochemical staining of benign metastasizing
leiomyoma (BML). Positive immunohistochemical staining for smooth
muscle makers α-smooth muscle actin (A, 20×), muscle specific actin
(B, 20×), desmin (C, 40×). Immunohistochemical analysis showed
strong expression of estrogen and progesterone receptors in tumor
cells (D and E, 40×).
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hormone sensitive and regressed. After 49 months, CT
showed that the lung nodules were unchanged. Data of
Case 1 are shown in Table 2.
Case 2
A 47-year-old woman had undergone hysterectomy and
unilateral ovariectomy for multiple leiomyomas of the
uterus and a right ovarian cyst 17 years previously. She
complained of abdominal pain and was referred to an-
other unit. A pelvic ultrasound scan showed a left ovary
mass, she was prepared for surgery. However, chest CT
scan revealed multiple nodules in both lungs during pre-
operative evaluation (Figure 4). The patient was referred
to our department and underwent PET-CT examination,
PET-CT did not show any appearance of malignant
signs in other parts of the body but moderately intense
accumulation of 18F-FDG in parts of the lung nodules.
She had no history of malignancy. The patient under-
went CT-guided hookwire localization and a pulmonary
wedge resection by VATS, pathology showed no cellular
atypia or necrosis or no mitotic figures and revealed that
lung nodules were BML (Figure 2B, E). Immunohisto-
chemical analyses are shown in Table 1. The patient ex-
perienced a unilateral ovariectomy one week after
thoracic surgery. Over 43 months follow-up, CT showed
that the lung nodules were unchanged. Data of Case 2
are shown in Table 2.Table 1 Immunohistochemical results
No. α-SMA MSA Desmin E
1 + + + +
2 + + + +
3 + Partial positive + +
α-SMA α-Smooth muscle actin, MSA Muscle specific actin, ER Estrogen receptor, PR PCase 3
Case 3 was a 53-year-old woman with a past medical
history of multiple uterine leiomyomas, she had under-
gone subtotal hysterectomy seven years previously. The
patient was asymptomatic and referred to our depart-
ment for accidental radiologic findings of multiple pul-
monary nodules involving both lungs (Figure 5). There
was no history of malignancy. PET-CT showed moder-
ately intense accumulation of 18F-FDG in parts of the
lung nodules. The patient underwent a pulmonary
wedge resection by VATS, pathology revealed that lung
nodules were BML (Figure 2C, F). Immunohistochemi-
cal analyses are shown in Table 1. She had a trachelec-
tomy and bilateral ovariectomy 11 days later after
thoracic surgery. Over 25 months follow-up, the patient
appeared well and chest CT scan showed the lung lesions
remained stable. Data of Case 3 are shown in Table 2.
Results
As we have introduced above, the ultimate pathologic
results ruled out the possibility of leiomyosarcoma and
other metastatic diseases, and confirmed that the pul-
monary lesions were BML in all three patients. All pa-
tients had a regular follow-up evaluation, including
clinical symptom and radiologic evaluation. The lung le-
sions remained stable in two patients who were treated
by surgical castration, and the lung nodules regressed in
one patient treated with gonadotropin-releasing hormone
analogues. We did not find any additional problems in
all patients.
Discussion
Uterine leiomyoma is the most common type of uterine
tumor and is typically considered benign, with a favor-
able long-term prognosis. However, there are two un-
usual growth patterns of leiomyoma that are important
to recognize. Both BML and disseminated peritoneal
leiomyomatosis are found outside the uterus [1]. BML
has been described as incidental pulmonary nodules in
women with a history of uterine leiomyomas [2]. It oc-
curs predominantly in women of reproductive age [3],
and the youngest reported patient was 23 years old [4].
Sometimes, the pulmonary lesions can be found simul-
taneously with uterine leiomyoma [5]. The mean time
period from hysterectomy to the appearance of lung le-
sions is 15 years [6].R PR Calponin Caldesmon Ki67
+ + + –
+ + N/A 3%
+ + + 5%
rogesterone receptor.
Table 2 Patient characteristics
No. Age (years) Primary lesion Treatment Interval time (years) Treatment for BML Follow-up (months)
1 47 Uterine leiomyoma Subtotal hysterectomy 7 GnRH-analogues 49
2 47 Uterine leiomyoma and
ovarian cyst
Hysterectomy + unilateral
ovariectomy
17 Unilateral ovariectomy 43
3 53 Uterine leiomyoma Subtotal hysterectomy 7 Trachelectomy + bilateral
ovariectomy
25
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vealed to have bilateral diffuse nodular opacities by a
routine chest roentgenogram, only a small percentage of
patients present with complaints of respiratory disease.
The further examination of CT chest scans show mul-
tiple varying sized nodular lesions in both lungs; there is
no mediastinal lymphadenopathy. Recently, BML was
evaluated with metabolic imaging 18F-FDG PET-CT and
the absent FDG uptake of the pulmonary lesions ruled
out metastasis from extrathoracic malignant tumors or
uterine sarcoma [7]. Lin et al. thought that non-avid or
mild uptake in 18F-FDG PET-CT without mediastinal
and hilar lymph node enlargement or appearance of ma-
lignant signs in other parts of the body were criteria in
the diagnosis of BML [8]. In the cases presented herein,
one patient was PET-negative and two other patients
showed moderately intense accumulation of 18F-FDG.
Biopsy through fine-needle aspiration (FNA) may miss
the tumor or retrieve only a small number of cells from
the lesions, with the risk that the abnormal cells will not
be sampled; further, the amount of tissue harvested is
usually insufficient. Therefore, VATS was performed in-
stead of FNA biopsy in order to harvest enough tissue
for histopathologic and immunohistochemical examin-
ation in patients.
Before making the diagnosis of BML, leiomyosarcoma
must be excluded. BML consists of well-differentiated
spindle-shaped cells with low nuclear and cellular varianceFigure 4 CT of Case 2 shows multiple nodules in both lungs.in size and shape; there is no disorganized growth pattern
and mitotic figures. Besides these indicators, Ki67 index for
the BML is less than that for leiomyosarcoma [9,10], and
the miRNA, miR-221 is upregulated in leiomyosarcoma.
The upregulation of miR-221 expression is an accurate
way to differentiate leiomyosarcoma from BML [11]. In
the cases herein, the morphological features and immu-
nohistochemical results have provided enough informa-
tion for the diagnosis of BML; thus, examinations related
to leiomyosarcoma and miR-221 were not performed.
Finally, for an accurate diagnosis of BML, a diagnosis of
smooth muscle tumors of uncertain malignant potential
(STUMP), according to the World Health Organization
classification [12], must be ruled out. Uterine smooth
muscle tumors that show some worrisome histological
features (i.e., necrosis, nuclear atypia, or mitoses), but
do not meet all diagnostic criteria for leiomyosarcoma,
fall into the category of STUMP [13]. All of our patients
were diagnosed with uterine leiomyoma after resection of
the uterine tumors and the pathological results of the lung
lesions did not show mitotic figures, nuclear atypia, and
tumor necrosis. Therefore, we prefer the diagnosis of BML
to that of metastasis of STUMP.
BML can have a benign indolent clinical course, with
long-term stability [14]. Giove et al. have reported a
BML case in a 55-year-old woman still living with lung,
skin, lymph nodes, bone, and perhaps brain metastases
14 years after the first uterine myomectomy [15]. Most
BML lesions are stable in number, size and clinical symp-
toms, or progress with low velocity; however, in some
cases, the lesions develop a giant tumor mass if no treat-
ment is performed [16]. Some authors have proposed thatFigure 5 X-ray and CT images for Case 3. Posteroanterior chest
X-ray reveals bilateral diffuse nodular opacities (A). CT shows multiple
nodules in both lungs (B).
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hormonal manipulation through surgical or medical oo-
phorectomy may succeed for BML [17,18]. Despite the
presence of positive estrogen and progesterone receptors
on smooth muscle cells, there was no significant change in
size of BML after 6 to 12 months treatment of tamoxifen,
progesterone, and an aromatase inhibitor [2]. Benetti-Pinto
et al. have performed the classic treatment of oophorec-
tomy for two patients with BML of the lung, and obtained
different outcomes; one achieved an improvement in
symptoms, the other did not [19]. Finally, some authors
propose that BML might naturally decrease following the
menopause [20]. However, cases of pulmonary BML from
the uterus in elderly postmenopausal women have been
reported [5,21]. Surgical castration combined with hormo-
nal therapy have also been used to treat BML [22]. Thus,
the standard treatment for BML is still controversial.
In our limited experiences, further treatment should
be offered to these patients following the diagnosis of
BML. If possible, surgical excision is the first choice for
treatment of BML. However, multiple nodules in both
lungs are the most common manifestation in patients
with BML and therefore it is impossible to perform the
primary excision for these patients; the therapeutic op-
tions available are surgical and/or chemical castration.
In our patients, both estrogen and progesterone recep-
tors were identified in the lung lesions (Table 2), chem-
ical castration was used in one patient and castration
surgery was performed on the other two. The results
were satisfactory; the lung lesions remained stable in pa-
tients who were treated by surgical castration, especially
for the patient who was treated with GnRH analogues,
and the lung nodules regressed. Despite performing sur-
gical castration in two patients, we preferred chemical
castration rather than surgical castration since it is po-
tentially reversible and can result in complete residual
tumor regression [23]. Even though medical castration
failed to achieve results, surgical castration may be a
good alternative. No further complications were encoun-
tered in the clinical follow-up of our patients.Conclusions
The diagnosis of BML is based on the medical history of
uterine myomas and histopathologic and immunohisto-
chemical examination of lung nodules. Video-assisted
thoracoscopic wedge resection is the best way to harvest
tissue for diagnosis. The better outcomes in BML seem
to call for medical intervention, either chemical or surgi-
cal, after diagnosis is made.
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